<< New method of viewing cancer cells shows how breast cancer spreads | Novel tool helps study the biochemical basis of Alzheimer's >>
Read in | English | Italiano | 한국어

Promising clinical trial for patients with obsessive-compulsive disorder

Published on November 12, 2008 at 9:28 PM · No Comments

Obsessive-compulsive disorder (OCD) affects 2% of the population and is considered a psychiatric disorder. It is the number four psychiatric pathology in terms of frequency following phobias, disorders relating to alcohol and drugs, and depression.

The people affected are obsessed with cleanliness, order, and symmetry, or are overcome by doubts and irrational fears. In order to reduce their anxiety, they carry out rituals of tidying, washing or verification for several hours a day in the most serious cases. These signs reflect major suffering and a serious handicap that often last for years, and should not be confused with obsessive, perfectionist and meticulous personality traits. One third of patients are resistant to the usual treatment, a combination of cognitive behavior therapy and anti-depressants (serotonin reuptake inhibitors). Hypotheses in favor of a dysfunction of the striato-pallido-thalamo-cortical cerebral circuits encouraged experimental attempts at psychosurgical treatment (destruction of certain parts of the incriminated cerebral areas or of their connections) in patients with the most serious cases. But the efficacy of these trials, which were never evaluated in a rigorous manner, is unclear because of uncertainty in the choice of the cerebral targets. Furthermore, the lesion is irreversible and thus open to criticism from an ethical standpoint. After several attempts, some neurosurgery teams tried to reproduce the effect of the lesions with the deep stimulation technique (see box). Despite interesting observations, a serious lack of precision concerning the choice of the anatomical target was reported.

In order to propose a reliable therapeutic alternative for the most severe forms of OCD, French researchers chose a different study approach. A small area of the brain that is involved in motor disturbances in Parkinson's Disease (the subthalamic nuclei) drew their attention. Stimulating it led to a substantial reduction in behavior disorders in two Parkinson's patients. In Parkinson's patients, the insertion of an electrode at the center of the subthalamic nucleus eliminates motor disturbances. But when the site of the stimulation is shifted by a few millimeters, changes in the psychic state and behavior of patients are observed. They may for example become hyperactive, insomniac or irritable. If the contact is changed again, these effects disappear. Previous research by Luc Mallet and his colleagues showed that depending on the precise localization of the electrode, one of the various aspects of behavior, motor, social or affective, could be modified .

A national study carried out at 10 university hospital centers

Deep cerebral stimulation was thus proposed as a therapeutic alternative for people with severe OCD in whom pharmacological and psychological treatments had no effect. This technique has the advantage of being reversible. It also allows for precise adjustment of the various stimulation parameters (frequency, voltage, pulse duration) to obtain the best result possible.

Sixteen patients, divided among 10 French university hospital centers, were selected for surgical implantation of an electrode in each subthalamic nucleus. Over the course of 10 months, they were monitored by the doctors, psychiatrists and researchers involved in the protocol for which AP-HP was the sponsor and the main investigator. The stimulator connected to the electrodes was activated and then deactivated in a randomized manner (order determined randomly): eight patients underwent a period of active stimulation followed by a period of "placebo" stimulation while eight others received "placebo" stimulation followed by real stimulation. "This was a double blind test, i.e. neither the patients nor the doctors knew the periods of stimulation," Luc Mallet explained.

There are various tools for the diagnosis of obsessive compulsive disorder. The researchers used them to objectively measure the evolution of the disorders in their patients. The suffering caused by the obsessions and compulsions, the time devoted to them, and the capacity of the patients to control these thoughts and behaviors were evaluated with a specific scale. The results were quite convincing. After the surgery and at the end of 3 months of active stimulation, 7 patients out of 10 showed a response to the treatment and an improvement in their condition: more than 25% of their symptoms had disappeared. The evaluation of the efficacy of the treatment also focused on the capacity of the patient to return to normal family life, to form new social ties, or to go back to work. After 3 months of active stimulation, 6 patients out of 10 reached satisfactory overall functioning with only moderate discomfort due to the illness. Only 12% of them reached this level with placebo stimulation.

Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.



  Country flag

biuquote
  • Comment
  • Preview
Loading